A case of Stevens-Johnson syndrome due to rifampicin
Journal: International Journal of Basic & Clinical Pharmacology (Vol.3, No. 1)Publication Date: 2014-02-01
Authors : Vandana A. Badar Dharmendra Mishra Swapnil Deshmukh Sangita Chaudhari;
Page : 239-241
Keywords : Rifampicin; Steven Johnson syndrome; Adverse drug reaction;
Abstract
A 25 year old female known case of category II pulmonary Tuberculosis was on anti-coch’s treatment in the FDC of rifampicin, isoniazid, pyrazinamide, ethambutol and Streptomycin. Fifteen days after the commencement of Cat II anti TB treatment she developed diffuse erythematous rash on face, trunk and both extremities which turned into blisters. There were ulcers on oral and genital cavity. A diagnosis of Stevens Johnson’s syndrome was made. The patient had a history of cat I pulmonary TB and treated for 8 months and at the end of 8th month she was sputum smear negative. Four months later she had a relapse of sputum smear positive for pulmonary TB. She responded to the stoppage of drugs and oral/inj. Corticosteroids, antihistaminics and antibiotics. [Int J Basic Clin Pharmacol 2014; 3(1.000): 239-241]
Other Latest Articles
- Metronidazole associated seizures: a case report and review of the pharmacovigilance literature
- Antipsychotic discontinuation syndrome following risperidone withdrawal: a case report from rural India
- Alcoholism with central pontine demyelination: a case report
- Serotonin syndrome due to fluoxetine and tramadol in renal impaired patient
- Clindamycin as trigger of uroporphyrinuria
Last modified: 2014-02-08 13:54:06